ストックスクリーナーアプリを入手
0.4871
1.24%
-0.0061
アフターアワーズ：
.48
-0.0071
-1.46%
前日終値:
$0.4932
開ける：
$0.4858
24時間の取引高:
395.99K
Relative Volume:
1.36
時価総額：
$38.35M
収益：
$9.53M
当期純損益:
$-44.61M
株価収益率:
-0.5353
EPS:
-0.91
ネットキャッシュフロー:
$-38.32M
1週間 パフォーマンス:
-11.24%
1か月 パフォーマンス:
-27.04%
6か月 パフォーマンス:
-23.38%
1年 パフォーマンス:
-53.39%
1日の値動き範囲:
$0.4662
$0.5069
1週間の範囲:
$0.4662
$0.55
52週間の値動き範囲:
$0.4662
$1.75
Cue Biopharma Inc Stock (CUE) Company Profile
CUE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.4871 | 38.83M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-13 | 開始されました | Jefferies | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2022-11-21 | 開始されました | Piper Sandler | Overweight |
| 2022-01-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-03 | 開始されました | Craig Hallum | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-04-09 | 開始されました | Stifel | Buy |
| 2020-01-28 | 開始されました | BTIG Research | Buy |
| 2020-01-22 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Cue Biopharma Inc (CUE) 最新ニュース
Does Cue Biopharma Inc (CUE) offer a good opportunity for investors? - Setenews
Cue Biopharma (CUE) Price Target Increased by 25.00% to 5.10 - Nasdaq
Will Cue Biopharma Inc. stock continue upward momentum2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
Is Cue Biopharma Inc. stock a safe investment in uncertain marketsDip Buying & Stepwise Trade Signal Implementation - Newser
How Cue Biopharma Inc. stock reacts to inflationary pressuresTrade Signal Summary & Real-Time Volume Triggers - Newser
Is Cue Biopharma Inc. (1UC) stock dividend growth reliableSwing Trade & Community Consensus Picks - Newser
Is Cue Biopharma Inc. (1UC) stock testing key supportStop Loss & Long-Term Safe Investment Ideas - Newser
What Wall Street predicts for Cue Biopharma Inc. stock price2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser
Will Cue Biopharma Inc. (1UC) stock benefit from infrastructure billQuarterly Earnings Report & Long-Term Capital Growth Strategies - Newser
How Cue Biopharma Inc. (1UC) stock moves in volatile trading sessionsOil Prices & High Conviction Buy Zone Alerts - Newser
Can Cue Biopharma Inc. stock rebound after recent weakness2025 Volume Leaders & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Is Cue Biopharma Inc (CUE) positioned for future growth? - Setenews
Will Cue Biopharma Inc. stock benefit from AI adoptionMarket Risk Summary & Community Supported Trade Ideas - moha.gov.vn
[Form 4] Cue Biopharma, Inc. Insider Trading Activity - Stock Titan
Cue Biopharma Releases Updated Corporate Presentation - TipRanks
[8-K] Cue Biopharma, Inc. Reports Material Event | CUE SEC FilingForm 8-K - Stock Titan
Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates - MSN
Can Cue Biopharma Inc. stock resist market sell offsGlobal Markets & Smart Swing Trading Alerts - newser.com
Will Cue Biopharma Inc. stock recover faster than peers2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Is Cue Biopharma Inc. stock dividend yield sustainableWeekly Trade Report & Verified Chart Pattern Signals - newser.com
Cue Biopharma Announces CMO Departure - TipRanks
Cue Biopharma Announces Departure of Chief Medical Officer - TradingView
Cue Biopharma, Inc. Announces Termination of Matteo Levisetti as Chief Medical Officer, Effective November 28, 2025 - MarketScreener
Why Cue Biopharma Inc. (1UC) stock benefits from AI revolutionEarnings Beat & Reliable Trade Execution Plans - newser.com
Is Cue Biopharma Inc. stock trading at a premium valuationPortfolio Risk Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Cue Biopharma Inc. (1UC) stock deliver compounding returns2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Asia Deal Watch: GSK To Collaborate With LTZ On Myeloid Cell Engagers - Citeline News & Insights
Why Cue Biopharma Inc. (1UC) stock could be next leader2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
How Cue Biopharma Inc. stock performs in rate cut cycles2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - newser.com
Can Cue Biopharma Inc. (1UC) stock expand revenue streams2025 Market Overview & Smart Investment Allocation Insights - newser.com
What dividend safety score for Cue Biopharma Inc. stockJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Is Cue Biopharma Inc. stock gaining market shareWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Is Cue Biopharma Inc. stock attractive for hedge fundsBond Market & Fast Entry Momentum Trade Alerts - newser.com
Trend analysis for Cue Biopharma Inc. this week2025 Market WrapUp & Safe Capital Allocation Plans - newser.com
Cue Biopharma Inc (CUE) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):